Schaeffer Orlov S Nicole's Form 4 filing
INSMED IncINSM · filed Jan 6, 2026
- Accession no.
- 0001401017-26-000002
- Filed
- Jan 6, 2026
- Trade date
- Jan 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $15.3M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schaeffer Orlov S NicoleCIK 0001401017 | Officer (Chief People Strategy Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | AGrant or awardAcquired | +5,293 | –F2 | – | 41,754 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +87,290 | $13.91 | +$1,214,203.9 | 129,044 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −31,030 | $174.28F4 | −$5,407,908.4 | 98,014 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −34,103 | $175.17F5 | −$5,973,822.51 | 63,911 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −12,832 | $176.08F6 | −$2,259,458.56 | 51,079 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −9,125 | $177.17F7 | −$1,616,676.25 | 41,954 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −200 | $177.78F8 | −$35,556 | 41,754 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | AGrant or awardAcquired | +27,600 | $0.00 | $0 | 27,600 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −87,290 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU was granted on January 2, 2026 for no consideration.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F5
This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F6
This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F7
This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F8
This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.